Cytochalasin D promotes pulmonary metastasis of B16 melanoma through expression of tissue factor

Oncology Reports

Volumn 30, Issue 1, 2013, Pages 478-484

  Huang, Feng Ying ^a   Mei, Wen Li ^b   Tan, Guang Hong ^a   Dai, Hao Fu ^b   Li, Yue Nan ^a   Guo, Jun Li ^a   Huang, Yong Hao ^a   Zhao, Huan Ge ^a   Wang, Hua ^a   Zhou, Song Lin ^a   Lin, Ying Ying ^a  

^a HAINAN MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF TROPICAL BIOSCIENCE AND BIOTECHNOLOGY   (China)

Author keywords

Clotting factor factor VII; Cytochalasin D; Mitogen activated protein kinase p38; Tissue factor; Tumor metastasis

Indexed keywords

BLOOD CLOTTING FACTOR 7A; CYTOCHALASIN D; DIMETHYL SULFOXIDE; LENTIVIRUS VECTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; THROMBOPLASTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COCULTURE; CONTROLLED STUDY; FEMALE; LUNG METASTASIS; LUNG WEIGHT; MELANOMA B16; MELANOMA CELL; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CELL LINE, TUMOR; CYTOCHALASIN D; FACTOR VIIA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NUCLEIC ACID SYNTHESIS INHIBITORS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; THROMBOPLASTIN; UP-REGULATION;

EID: 84878182556     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2423     Document Type: Article

References (48)

1. Talmadge JE: Clonal selection of metastasis within the life history of a tumor. Cancer Res 67: 11471-11475, 2007.
2. Manavathi B and Kumar R: Metastasis tumor antigens, an emerging family of multifaceted master coregulators. J Biol Chem 282: 1529-1533, 2007. (Pubitemid 47076673)
3. Langley RR and Fidler IJ: Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev 28: 297-321, 2007. (Pubitemid 46984829)
4. Denko NC and Giaccia AJ: Tumor hypoxia, the physiological link between Trousseau's syndrome (carcinoma-induced coagulopathy) and metastasis. Cancer Res 61: 795-798, 2001. (Pubitemid 32174380)
5. Orfeo T, Butenas S, Brummel-Ziedins KE and Mann KG: The tissue factor requirement in blood coagulation. J Biol Chem 280: 42887-42896, 2005. (Pubitemid 43049251)
6. Vestjens JH, Sassen S and Prins MH: Blood coagulation and cancer: thrombosis and survival, clinical relevance and impact. An introduction. Pathophysiol Haemost Thromb 36: 113-121, 2008.
7. Boccaccio C and Medico E: Cancer and blood coagulation. Cell Mol Life Sci 63: 1024-1027, 2006. (Pubitemid 43800772)
8. Sawada M, Miyake S, Ohdama S, et al: Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis. Br J Cancer 79: 472-477, 1999. (Pubitemid 29046221)
9. Koomagi R and Volm M: Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis. Int J Cancer 79: 19-22, 1998. (Pubitemid 28157720)
10. Amarzguioui M, Peng Q, Wiiger MT, et al: Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells. Clin Cancer Res 12: 4055-4061, 2006. (Pubitemid 44078093)
11. Amirkhosravi A, Meyer T, Chang JY, et al: Tissue factor pathway inhibitor reduces experimental lung metastasis of B16 melanoma. Thromb Haemost 87: 930-936, 2002. (Pubitemid 34624872)
12. Mueller BM, Reisfeld RA, Edgington TS and Ruf W: Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci USA 89: 11832-11836, 1992. (Pubitemid 23004738)
13. Bromberg ME, Konigsberg WH, Madison JF, Pawashe A and Garen A: Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci USA 92: 8205-8209, 1995.
14. Udagawa T, Yuan J, Panigrahy D, Chang YH, Shah J and D'Amato RJ: Cytochalasin E, an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor growth. J Pharmacol Exp Ther 294: 421-427, 2000. (Pubitemid 30490811)
15. Bousquet PF, Paulsen LA, Fondy C, Lipski KM, Loucy KJ and Fondy TP: Effects of cytochalasin B in culture and in vivo on murine Madison 109 lung carcinoma and on B16 melanoma. Cancer Res 50: 1431-1439, 1990. (Pubitemid 20090451)
16. Cooper JA: Effects of cytochalasin and phalloidin on actin. J Cell Biol 105: 1473-1478, 1987.
17. Kustermans G, Piette J and Legrand-Poels S: Actin-targeting natural compounds as tools to study the role of actin cytoskeleton in signal transduction. Biochem Pharmacol 76: 1310-1322, 2008.
18. Miyazaki J, Nishiyama H, Yano I, et al: The therapeutic effects of R8-liposome-BCG-CWS on BBN-induced rat urinary bladder carcinoma. Anticancer Res 31: 2065-2071, 2011.
19. Nemeth ZH, Deitch EA, Davidson MT, Szabo C, Vizi ES and Hasko G: Disruption of the actin cytoskeleton results in nuclear factor-kappaB activation and inflammatory mediator production in cultured human intestinal epithelial cells. J Cell Physiol 200: 71-81, 2004. (Pubitemid 38720623)
20. Mortensen K and Larsson LI: Effects of cytochalasin D on the actin cytoskeleton: association of neoformed actin aggregates with proteins involved in signaling and endocytosis. Cell Mol Life Sci 60: 1007-1012, 2003. (Pubitemid 36735129)
21. Milsom C and Rak J: Regulation of tissue factor and angiogenesis-related genes by changes in cell shape. Biochem Biophys Res Commun 337: 1267-1275, 2005. (Pubitemid 41505259)
22. Huang JL, Dai HF, Wang H, et al: Cytotoxic active metabolites from endophytic fungus S15 From Hainan Plum-Yew (Cephalotaxus hainanensis). J Microbiol (Chinese) 30: 10-14, 2010.
23. Tan GH, Wei YQ, Tian L, et al: Active immunotherapy of tumors with a recombinant xenogeneic endoglin as a model antigen. Eur J Immunol 34: 2012-2021, 2004. (Pubitemid 39256082)
24. Tan GH, Tian L, Wei YQ, et al : Combination of low-dose cisplatin and recombinant xenogeneic endoglin as a vaccine induces synergistic antitumor activities. Int J Cancer 112: 701-706, 2004. (Pubitemid 39425953)
25. Apte RS, Niederkorn JY, Mayhew E and Alizadeh H: Angiostatin produced by certain primary uveal melanoma cell lines impedes the development of liver metastases. Arch Ophthalmol 119: 1805-1809, 2001. (Pubitemid 33139611)
26. Chen SX, Huang FY, Tan GH, et al: RNA interference against interleukin-5 attenuates airway inflammation and hyperresponsiveness in an asthma model. J Zhejiang Univ Sci B 10: 22-28, 2009.
27. Ailenberg M and Silverman M: Cytochalasin D disruption of actin filaments in 3T3 cells produces an anti-apoptotic response by activating gelatinase A extracellularly and initiating intracellular survival signals. Biochim Biophys Acta 1593: 249-258, 2003. (Pubitemid 36173493)
28. Pollard TD, Blanchoin L and Mullins RD: Molecular mechanisms controlling actin filament dynamics in nonmuscle cells. Annu Rev Biophys Biomol Struct 29: 545-576, 2000. (Pubitemid 30599604)
29. Levee MG, Dabrowska MI, Lelli JL Jr and Hinshaw DB: Actin polymerization and depolymerization during apoptosis in HL-60 cells. Am J Physiol 271: C1981-C1992, 1996. (Pubitemid 27030577)
30. Seufferlein T and Rozengurt E: Lysophosphatidic acid stimulates tyrosine phosphorylation of focal adhesion kinase, paxillin, and p130. Signaling pathways and cross-talk with platelet-derived growth factor. J Biol Chem 269: 9345-9351, 1994.
31. Frisch SM and Francis H: Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124: 619-626, 1994. (Pubitemid 24064472)
32. Zhang C, Zhang F, Tsan R and Fidler IJ: Transforming growth factor-beta2 is a molecular determinant for site-specific melanoma metastasis in the brain. Cancer Res 69: 828-835, 2009.
33. Ueno T, Toi M, Koike M, Nakamura S and Tominaga T: Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration. Br J Cancer 83: 164-170, 2000. (Pubitemid 30411712)
34. Rickles FR, Patierno S and Fernandez PM: Tissue factor, thrombin, and cancer. Chest 124 (Suppl 3): 58S-68S, 2003. (Pubitemid 37128437)
35. Fernandez PM, Patierno SR and Rickles FR: Tissue factor and fibrin in tumor angiogenesis. Semin Thromb Hemost 30: 31-44, 2004. (Pubitemid 38457299)
36. Staton CA, Brown NJ and Lewis CE: The role of fibrinogen and related fragments in tumour angiogenesis and metastasis. Expert Opin Biol Ther 3: 1105-1120, 2003. (Pubitemid 37295766)
37. Dupuy E, Habib A, Lebret M, Yang R, Levy-Toledano S and Tobelem G: Thrombin induces angiogenesis and vascular endothelial growth factor expression in human endothelial cells: possible relevance to HIF-1alpha. J Thromb Haemost 1: 1096-1102, 2003.
38. Wang X, Gjernes E and Prydz H: Factor VIIa induces tissue factor-dependent up-regulation of interleukin-8 in a human keratinocyte line. J Biol Chem 277: 23620-23626, 2002. (Pubitemid 34952199)
39. Nakasaki T, Wada H, Shigemori C, et al: Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol 69: 247-254, 2002. (Pubitemid 34259846)
40. Zhang Y, Deng Y, Luther T, et al: Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 94: 1320-1327, 1994. (Pubitemid 24286478)
41. Ollivier V, Chabbat J, Herbert JM, Hakim J and de Prost D: Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa. Arterioscler Thromb Vasc Biol 20: 1374-1381, 2000. (Pubitemid 30262941)
42. Bromberg ME, Sundaram R, Homer RJ, Garen A and Konigsberg WH: Role of tissue factor in metastasis: functions of the cytoplasmic and extracellular domains of the molecule. Thromb Haemost 82: 88-92, 1999. (Pubitemid 29368778)
43. Røttingen JA, Enden T, Camerer E, Iversen JG and Prydz H: Binding of human factor VIIa to tissue factor induces cytosolic Ca2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor. J Biol Chem 270: 4650-4660, 1995.
44. Abe K, Shoji M, Chen J, et al: Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Acad Sci USA 96: 8663-8668, 1999. (Pubitemid 29354848)
45. Sorensen BB, Rao LV, Tornehave D, Gammeltoft S and Petersen LC: Antiapoptotic effect of coagulation factor VIIa. Blood 102: 1708-1715, 2003. (Pubitemid 37022564)
46. Camerer E, Gjernes E, Wiiger M, Pringle S and Prydz H: Binding of factor VIIa to tissue factor on keratinocytes induces gene expression. J Biol Chem 275: 6580-6585, 2000. (Pubitemid 30129959)
47. Wang X, Wang M, Amarzguioui M, Liu F, Fodstad O and Prydz H: Downregulation of tissue factor by RNA interference in human melanoma LOX-L cells reduces pulmonary metastasis in nude mice. Int J Cancer 112: 994-1002, 2004. (Pubitemid 39507005)
48. Poggi A, Rossi C, Casella N, et al: Inhibition of B16-BL6 melanoma lung colonies by semisynthetic sulfaminoheparosan sulfates from E. coli K5 polysaccharide. Semin Thromb Hemost 28: 383-392, 2002.